• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

筛选和鉴定一种能抑制骨髓瘤细胞增殖的膜联蛋白 A2 结合适体。

Screening and characterization of an Annexin A2 binding aptamer that inhibits the proliferation of myeloma cells.

机构信息

Molecular Biology Research Center, School of Life Sciences, Central South University, Changsha, 410078, China; Department of Biochemistry, College of Medicine, Jishou University, Jishou, 416000, China.

Molecular Biology Research Center, School of Life Sciences, Central South University, Changsha, 410078, China.

出版信息

Biochimie. 2018 Aug;151:150-158. doi: 10.1016/j.biochi.2018.06.003. Epub 2018 Jun 15.

DOI:10.1016/j.biochi.2018.06.003
PMID:29906496
Abstract

Multiple myeloma (MM) is a malignant plasma cell disease and is considered incurable. Annexin A2 (ANXA2) is closely related to the proliferation and adhesion of MM. Using protein-SELEX, we performed a screen for aptamers that bind GST-ANXA2 from a library, and GST protein was used for negative selection. The enrichment of the ssDNA pool was monitored by filter-binding assay during selection. After nine rounds of screening and high-throughput sequencing, we obtained six candidate aptamers that bind to the ANXA2 protein. The affinities of the candidate aptamers for ANXA2 were determined by ELONA. Binding of aptamer wh6 to the ANXA2 protein and to the MM cell was verified by aptamer pulldown experiment and flow cytometry, respectively. Aptamer wh6 binds the ANXA2 protein with good stability and has a dissociation constant in the nanomolar range. The binding specificity of aptamer wh6 was confirmed in vivo in nude mouse xenografts with MM cells and with MM bone marrow aspirates. Furthermore, aptamer wh6 can block MM cell adhesion to ANXA2 and block the proliferation of MM cells induced by ANXA2. In summary, wh6 can be considered a promising candidate tool for MM diagnosis and treatment.

摘要

多发性骨髓瘤(MM)是一种恶性浆细胞疾病,被认为是不可治愈的。膜联蛋白 A2(ANXA2)与 MM 的增殖和黏附密切相关。我们使用蛋白质 SELEX 从文库中筛选与 GST-ANXA2 结合的适体,并用 GST 蛋白进行阴性选择。在筛选过程中,通过滤膜结合实验监测 ssDNA 池的富集情况。经过九轮筛选和高通量测序,我们获得了六个与 ANXA2 蛋白结合的候选适体。通过 ELONA 测定候选适体对 ANXA2 的亲和力。通过适体下拉实验和流式细胞术分别验证了适体 wh6 与 ANXA2 蛋白和 MM 细胞的结合。适体 wh6 与 ANXA2 蛋白具有良好的稳定性结合,解离常数在纳摩尔范围内。在携带 MM 细胞的裸鼠异种移植和 MM 骨髓抽吸物中体内验证了适体 wh6 的结合特异性。此外,适体 wh6 可以阻断 MM 细胞与 ANXA2 的黏附,并阻断 ANXA2 诱导的 MM 细胞增殖。总之,wh6 可以被认为是 MM 诊断和治疗的有前途的候选工具。

相似文献

1
Screening and characterization of an Annexin A2 binding aptamer that inhibits the proliferation of myeloma cells.筛选和鉴定一种能抑制骨髓瘤细胞增殖的膜联蛋白 A2 结合适体。
Biochimie. 2018 Aug;151:150-158. doi: 10.1016/j.biochi.2018.06.003. Epub 2018 Jun 15.
2
From ugly duckling to swan: unexpected identification from cell-SELEX of an anti-Annexin A2 aptamer targeting tumors.从丑小鸭到天鹅:通过细胞SELEX意外鉴定出一种靶向肿瘤的抗膜联蛋白A2适配体
PLoS One. 2014 Jan 29;9(1):e87002. doi: 10.1371/journal.pone.0087002. eCollection 2014.
3
Clinical and prognostic role of annexin A2 in multiple myeloma.膜联蛋白 A2 在多发性骨髓瘤中的临床和预后作用。
Blood. 2012 Aug 2;120(5):1087-94. doi: 10.1182/blood-2012-03-415588. Epub 2012 Jun 15.
4
Overexpression of Annexin II affects the proliferation, apoptosis, invasion and production of proangiogenic factors in multiple myeloma.膜联蛋白II的过表达影响多发性骨髓瘤的增殖、凋亡、侵袭及促血管生成因子的产生。
Int J Hematol. 2009 Sep;90(2):177-185. doi: 10.1007/s12185-009-0356-8. Epub 2009 Jul 8.
5
An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.一种用于筛选与化脓性链球菌M11型结合的DNA适配体的改良SELEX技术。
Methods. 2016 Mar 15;97:51-7. doi: 10.1016/j.ymeth.2015.12.005. Epub 2015 Dec 8.
6
[Apoptosis-inducing effect of annexin A2 on multiple myeloma cells and its related mechanisms].膜联蛋白A2对多发性骨髓瘤细胞的凋亡诱导作用及其相关机制
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Dec;20(6):1384-8.
7
Hi-Fi SELEX: A High-Fidelity Digital-PCR Based Therapeutic Aptamer Discovery Platform.高保真SELEX:一种基于高保真数字PCR的治疗性适配体发现平台。
Biotechnol Bioeng. 2015 Aug;112(8):1506-22. doi: 10.1002/bit.25581.
8
Generating lung-metastatic osteosarcoma targeting aptamers for in vivo and clinical tissue imaging.生成用于体内和临床组织成像的肺转移骨肉瘤靶向适体。
Talanta. 2018 Oct 1;188:66-73. doi: 10.1016/j.talanta.2018.05.011. Epub 2018 May 18.
9
Aptamer selection by high-throughput sequencing and informatic analysis.高通量测序和信息学分析的适体选择。
Biotechniques. 2011 Dec;51(6):413-6. doi: 10.2144/000113786.
10
Advancements in Aptamer Discovery Technologies.适体发现技术的进展。
Acc Chem Res. 2016 Sep 20;49(9):1903-10. doi: 10.1021/acs.accounts.6b00283. Epub 2016 Aug 15.

引用本文的文献

1
Nucleic acid aptamers in orthopedic diseases: promising therapeutic agents for bone disorders.骨科疾病中的核酸适配体:治疗骨病的潜在治疗剂。
Bone Res. 2025 Jul 24;13(1):71. doi: 10.1038/s41413-025-00447-8.
2
Aptamer-based approaches in leukemia: a paradigm shift in targeted therapy.基于适配体的白血病治疗方法:靶向治疗的范式转变。
Clin Exp Med. 2025 May 30;25(1):186. doi: 10.1007/s10238-025-01724-w.
3
A Double-Stranded Aptamer for Highly Sensitive Fluorescent Detection of Glutathione S-Transferases.双链适体用于谷胱甘肽 S-转移酶的高灵敏度荧光检测。
Biosensors (Basel). 2024 Oct 3;14(10):476. doi: 10.3390/bios14100476.
4
Leveraging diverse cellular stress patterns for predicting clinical outcomes and therapeutic responses in patients with multiple myeloma.利用多种细胞应激模式预测多发性骨髓瘤患者的临床结局和治疗反应。
J Cell Mol Med. 2024 Sep;28(17):e70054. doi: 10.1111/jcmm.70054.
5
Targeted Delivery Strategies for Multiple Myeloma and Their Adverse Drug Reactions.多发性骨髓瘤的靶向递送策略及其药物不良反应
Pharmaceuticals (Basel). 2024 Jun 25;17(7):832. doi: 10.3390/ph17070832.
6
The Research Advances of Aptamers in Hematologic Malignancies.适体在血液系统恶性肿瘤中的研究进展
Cancers (Basel). 2023 Jan 1;15(1):300. doi: 10.3390/cancers15010300.
7
Aptamers, a New Therapeutic Opportunity for the Treatment of Multiple Myeloma.适配体:治疗多发性骨髓瘤的新治疗机遇
Cancers (Basel). 2022 Nov 7;14(21):5471. doi: 10.3390/cancers14215471.
8
Race for the Cure: From the Oldest to the Newest Monoclonal Antibodies for Multiple Myeloma Treatment.多发性骨髓瘤治疗的单抗药物竞赛:从最古老到最新。
Biomolecules. 2022 Aug 19;12(8):1146. doi: 10.3390/biom12081146.
9
Nucleic acid aptamer controls mycoplasma infection for inhibiting the malignancy of esophageal squamous cell carcinoma.核酸适体通过控制支原体感染抑制食管鳞癌细胞的恶性转化。
Mol Ther. 2022 Jun 1;30(6):2224-2241. doi: 10.1016/j.ymthe.2022.02.018. Epub 2022 Feb 18.
10
Annexin Animal Models-From Fundamental Principles to Translational Research. annexin 动物模型——从基础原理到转化研究。
Int J Mol Sci. 2021 Mar 26;22(7):3439. doi: 10.3390/ijms22073439.